PepGen PEPG
NASDAQ PEPG
$3.11 -0.07 (-2.20%)
As of: Sep 4, 2026 · 3:59 PM EDT

PepGen (PEPG) Accumulated Depreciation (2021 - 2026)

PepGen (PEPG) posted Accumulated Depreciation of $4.2 million for Q1 2026, up 8.13% sequentially from $3.9 million in Q4 2025, and up 23.4% YoY from $3.4 million in Q1 2025.

Analysis

PepGen (PEPG) Accumulated Depreciation (2021 - 2026) Analysis & Trends

PepGen has reported Accumulated Depreciation for 6 years, with the latest figure at $4.2 million in Q1 2026.

  • Quarterly Accumulated Depreciation rose 23.4% year-over-year to $4.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.2 million (up 23.4% YoY) and the FY2025 annual result came in at $3.9 million, up 28.4% from the prior year.
  • Accumulated Depreciation improved to $4.2 million in Q1 2026 per PEPG's latest filing, from $3.9 million in the prior quarter.
  • Over five years, Accumulated Depreciation peaked at $4.2 million in Q1 2026 and troughed at $245000.0 in Q3 2022.
  • A 5-year average of $2.0 million and a median of $1.9 million in 2024 frame the typical range for Accumulated Depreciation.
  • The sharpest annual moves came in 2022 and 2023: Accumulated Depreciation declined 9.53% in 2022, then jumped 397.96% in 2023.
  • Over 5 years, Accumulated Depreciation stood at $389000.0 in 2022, then surged by 304.11% to $1.6 million in 2023, then surged by 93.77% to $3.0 million in 2024, then climbed by 28.4% to $3.9 million in 2025, then grew by 8.13% to $4.2 million in 2026.
  • According to Business Quant data, Accumulated Depreciation over the past three periods registered $4.2 million, $3.9 million, and $3.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 PepGen 217.99 Mn 217.99 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.48 Mn
Mar 31, 2026 4.23 Mn
Dec 31, 2025 3.91 Mn
Sep 30, 2025 3.58 Mn
Jun 30, 2025 3.24 Mn
Mar 31, 2025 3.43 Mn
Dec 31, 2024 3.05 Mn
Sep 30, 2024 2.69 Mn
Jun 30, 2024 2.31 Mn
Mar 31, 2024 1.94 Mn
Dec 31, 2023 1.57 Mn
Sep 30, 2023 1.22 Mn
Jun 30, 2023 871,000.00
Mar 31, 2023 540,000.00
Dec 31, 2022 389,000.00
Sep 30, 2022 245,000.00
Jun 30, 2022 415,000.00
Mar 31, 2022 471,000.00
Dec 31, 2021 430,000.00